More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Shelled Eggs
Antitrust, Commodities
On June 8, Lowey Dannenberg Chairman Vincent Briganti was appointed as Co-Lead Counsel for the Direct Purchaser Plaintiffs in In Re: Shell Eggs Antitrust Litigation, No. 3:26-md-03175-JDP (W.D. Wisc.) Plaintiffs […]
Amitza
Healthcare
Lowey Dannenberg, on behalf of named plaintiff Premera Blue Cross, is leading a class on behalf of Third-Party Payers of Amitiza (Lubiprostone) against Takeda Pharmaceutical Company Ltd. and related entities. […]
Amgen
Health Care, Healthcare
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. […]
News
Seven Lowey Dannenberg Attorneys Named as 2023 New York Metro Super Lawyers and Rising Stars
Lowey Dannenberg, P.C. is pleased to announce that seven of its attorneys were selected for inclusion in the 2023 Super Lawyers and Rising Stars lists for the New York Metro area. The Super Lawyers list recognizes no more than 5 percent of attorneys in each...
Blog
Securities or Not? The NFT Market and Potential SEC Regulation
In an economy that has witnessed increasing digitization of all sorts of assets, it is no surprise that non-fungible tokens, or NFTs, have gained attention across the investor spectrum. Yet much confusion still surrounds what NFTs are and why people are drawn to them. Put simply, NFTs are digital...